医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Fujifilm Completes Acquisition of Irvine Scientific Sales Company and IS Japan, Leading Companies of Cell Culture Media

2018年06月05日 PM06:31
このエントリーをはてなブックマークに追加


 

SANTA ANA, Calif.

FUJIFILM Corporation (President: Kenji Sukeno) announced today that it has completed the acquisition of Irvine Scientific Sales Company, Inc. (ISUS) and IS JAPAN CO.,LTD. (ISJ), leading companies in cell culture media for about US$800 million on June 1 in the United States.

To advance its growth strategies in the healthcare area, Fujifilm continues to invest in contract development and manufacturing of biopharmaceuticals and regenerative medicine. At FUJIFILM Diosynth Biotechnologies (FDB), manufacturing capacity for antibody drugs has been increased. FUJIFILM Cellular Dynamics (FCDI), a world-class developer and manufacturer of iPS cell technologies and know-how, is now a wholly owned subsidiary, and to enter the cell culture media business, Fujifilm acquired FUJIFILM Wako Pure Chemical, a leading reagent manufacturer.

With the acquisition of ISUS and ISJ, Fujifilm will now be able to provide a broad product portfolio from biopharmaceuticals to in vitro fertilization and cell therapy, strengthening its global business in addition to expanding domestic business through strong sales network in Japan. Utilizing its advanced chemical synthesis and design capabilities cultivated in the photographic film business and the cell preparation and culturing technologies of its group companies such as Japan Tissue Engineering, FCDI and FDB, Fujifilm will accelerate the development of highly competitive cell culture media, supporting the further growth of its cell culture media business. Further, by combining the Fujifilm Group’s bio-medical-related technologies and products with the cell culture media technologies and products of ISUS and ISJ, the company will expand the contact development and manufacturing business for biopharmaceuticals and reagent business, and also accelerate research and development in the area of regenerative medicine.

<Company Overview of ISUS and ISJ> (As of June 5, 2018)

    ISUS   ISJ
Company Name Irvine Scientific Sales Company, Inc. IS JAPAN CO.,LTD.
Location Santa Ana, California, U.S.A. Toda, Saitama, Japan
Year of incorporation 1970 1989
CEO Yutaka Yamaguchi Masatoshi Kato
Shareholder FUJIFILM Holdings America Corporation(100%) FUJIFILM(100%)

ENDS

For a high-resolution image please contact lorna.cuddon@zymecommunications.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20180605005803/en/

CONTACT

Irvine Scientific
Lori Serles
Phone: 949-261-7800 x145
Email:
lserles@irvinesci.com
or
Zyme
Communications

Lorna Cuddon
Phone: +44 (0)7811996942
Email:
lorna.cuddon@zymecommunications.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Exactech Earns Research Award at International Computer-Assisted Surgery Conference for ExactechGPS® Knee Application
  • 火山噴火で家屋の破壊と住民の避難が続く中、ハワイ・コミュニティ財団が支援基金を創設
  • Octapharma宣布Nuwiq®产品新增剂量规格在欧洲获准,提高了血友病A患者的给药灵活性
  • PHCホールディングス株式会社:薬剤師の業務効率化を目指した保険薬局用電子薬歴システム「PharnesV-MX」を販売開始
  • LG化学举办“全球创新大赛 (GIC)”“寻找改变世界的创新技术”